Inclusion Criteria:

1. Capable of giving written informed consent, and willing and able to comply with the
requirements and restrictions listed in the consent form.

2. Male or female patients >18 years of age at screening with histological or
cytological diagnosis of Non-Hodgkin's Lymphoma and due to receive intravenous
chemotherapy for the first time

3. A female subject is eligible to participate if she has non-childbearing potential

4. Male subject must agree to use one of the contraception methods listed

5. Able to lie comfortably on back for up to 70 minutes at a time.

6. WHO performance status 0, 1 or 2 -

Exclusion Criteria:

1. Patients with known history of Hepatitis B, C, non-A, non-B and HIV

2. Any clinically significant medical conditions that in the opinion of the investigator
would compromise the compliance with study procedures.

3. Pregnant or breast feeding females.

4. Any other prior anticancer therapy

5. Any new investigational agent, including an investigational anti-cancer agent

6. History of sensitivity to heparin or heparin-induced thrombocytopenia.

7. Males and females not able to comply with contraceptive guidelines during the study.

-